Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Sucampo Pharmaceuticals, Inc. | c97731e10vk.htm |
| EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | c97731exv31w1.htm |
| EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | c97731exv32w2.htm |
| EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc. | c97731exv32w1.htm |
| EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | c97731exv31w2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.
333-147420) of Sucampo Pharmaceuticals, Inc. of our report dated March 15, 2010 relating to the
financial statements, financial statement schedule and the effectiveness of internal control over
financial reporting, which appears in this Form 10-K.
| /s/ PricewaterhouseCoopers LLP | ||||
| Baltimore, Maryland | ||||
| March 15, 2010 | ||||